ARCHIVES

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

This article is from The Cancer Letter archive.

Vol. 22 No. 14 | April 4, 1996

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of February

February 22, 2013

Ellen Stoval Calls For More Funding for All Cancer Research

June 6, 1997

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Final Issue Of 1992

December 11, 1992

MSKCC Wins Zoning Request For New Labs.

February 8, 2002